BioEclosion develops and produces new clinical diagnostic devices based on state-of-the-art biosensors. The company's product "Celifast" helps enable the fast diagnosis of celiac disease at the point of care.
BioEclosion Headquarter Location
Edifici EUREKA, Av. de Can Domenech
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections containing BioEclosion
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
BioEclosion is included in 2 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting